Back
Arcus Biosciences, Inc. Vs. NIKE, Inc. Industry Stock Comparison
Sell
26
RCUS
Arcus Biosciences, Inc.
Last Price:
$23.11
Seasonality Move:
-9.85%
Sell
36
NKE
NIKE, Inc.
Last Price:
$59.97
Seasonality Move:
3.94%
Sell
26
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. a Buy, Sell or Hold?
-
The current Arcus Biosciences, Inc. [RCUS] share price is $23.12. The Score for RCUS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
NIKE, Inc. (NKE)
is a Sell
Is NIKE, Inc. a Buy, Sell or Hold?
-
The current NIKE, Inc. [NKE] share price is $60.00. The Score for NKE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NKE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCUS Stock Price Chart
What is Arcus Biosciences, Inc.'s stock price today?
-
The Arcus Biosciences, Inc. share price today is $23.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKE Stock Price Chart
What is NIKE, Inc.'s stock price today?
-
The NIKE, Inc. share price today is $60.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing slight buying pressure.
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.98 | Buy |
| Relative Strength Index (14 RSI): | 52.96 | Buy |
| Chaikin Money Flow: | 388340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.93 - 25.49) | Sell |
| Bollinger Bands (100): | (11.22 - 21.9) | Buy |
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.31 | Sell |
| Relative Strength Index (14 RSI): | 39.74 | Sell |
| Chaikin Money Flow: | 11457114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.88 - 66.82) | Sell |
| Bollinger Bands (100): | (63.54 - 74.44) | Sell |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.43 | Buy |
| 20-day SMA: | 24.09 | Sell |
| 50-day SMA: | 21.33 | Buy |
| 200-day SMA: | 12.66 | Buy |
| 8-day EMA: | 17.68 | Buy |
| 20-day EMA: | 10.21 | Buy |
| 50-day EMA: | 4.82 | Buy |
| 200-day EMA: | 1.31 | Buy |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.44 | Sell |
| 20-day SMA: | 64.19 | Sell |
| 50-day SMA: | 64.53 | Sell |
| 200-day SMA: | 66.93 | Sell |
| 8-day EMA: | 61.28 | Sell |
| 20-day EMA: | 63.15 | Sell |
| 50-day EMA: | 64.94 | Sell |
| 200-day EMA: | 69.09 | Sell |
Arcus Biosciences, Inc. Earnings Growth & RCUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.
NIKE, Inc. Earnings Growth & NKE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.26 per share, a decrease this year of $1.58 per share, and a decrease next year of $0.58 per share.
Arcus Biosciences, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NIKE, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||